Category - New Drug Applications
Camurus Provides Regulatory Update on the US NDA for CAM2029 in Acromegaly
Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
Sammy Basso, Advocate for Progeria Research, Is Dead at 28
CVS Ousts Karen Lynch as C.E.O. and Shares Fall
States Revive Lawsuit to Sharply Curb Access to Abortion Pill
Biden to Propose That Insurers Cover Over-the-Counter Birth Control